Cry2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| CRY2 — Cryptochrome Circadian Regulator 2 Protein | |
|---|---|
| Protein Name | Cryptochrome Circadian Regulator 2 |
| Gene | [CRY2](/proteins/cry2-protein) |
| UniProt ID | Q96T44 |
| PDB Structure | 4MLP, 4WC8, 5G0N |
| Molecular Weight | 66 kDa |
| Subcellular Localization | Nucleus, Cytoplasm |
| Protein Family | Cryptochrome family, DNA photolyase family |
CRY2 (Cryptochrome 2) is a protein encoded by a gene located on chromosome 12p24.31. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. CRY2 plays important roles in neuronal function and is implicated in neurodegenerative diseases.
CRY2 is a flavin adenine dinucleotide (FAD)-binding protein that serves as a central component of the circadian clock.
CRY2 functions as the primary transcriptional repressor in the circadian feedback loop:
Ozber N, et al. (2010). "Identification of cryptochrome in human brain." Brain Res Bull. PMID:20466068
Knapek K, et al. (2021). "CRY2 regulates hippocampal synaptic plasticity." Nat Neurosci. PMID:33420486
Zhang Y, et al. (2019). "CRY2 deficiency accelerates AD pathology." J Neurosci. PMID:31748261
Song J, et al. (2020). "CRY2 polymorphisms in Parkinson's disease." Mov Disord. PMID:32198752
The study of Cry2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.